The TGA adverse event reporting is a key part of post-market surveillance, ensuring that therapeutic goods, including medical devices, remain safe and effective after being introduced to the market. Sponsors are crucial in identifying, documenting, and reporting adverse events that could pose risks to patients, healthcare professionals, or caregivers.
What Qualifies as an Adverse Event?
An adverse event is any unintended or harmful occurrence linked to a medical device. This may include:
- Malfunctions or defects that may cause harm;
- Serious injury, illness, or death linked to device use; or
- Near misses, where an incident could have resulted in serious harm if not prevented.
An adverse event does not always indicate a fault in the device itself. User errors, interactions between devices, or environmental factors can also contribute to these events.
When and How Should Sponsors Report?
Sponsors must follow strict timelines when reporting adverse events:
- Within 10 days for events causing serious injury, illness, or death
- Within 30 days for incidents that could have led to serious harm but did not
To ensure timely action, reports must be submitted via the Therapeutic Goods Administration (TGA) Adverse Event Management System (AEMS).
How to Ensure Compliance with Post-Market Surveillance
To meet post-market surveillance obligations, sponsors should:
- Implement a structured system to detect and document adverse events.
- Educate staff on recognising and reporting potential risks.
- Maintain accurate records to demonstrate compliance with regulatory requirements.
Expert Guidance for Regulatory Compliance
Managing post-market surveillance can be complex. With extensive experience in medical device regulations, Vicki Partridge provides expert support to sponsors navigating TGA adverse event reporting requirements.
Contact her today on +61 7 55295508 to ensure your reporting processes meet compliance standards.